BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 30423196)

  • 21. Loss of wild-type ATRX expression in somatic cell hybrids segregates with activation of Alternative Lengthening of Telomeres.
    Bower K; Napier CE; Cole SL; Dagg RA; Lau LM; Duncan EL; Moy EL; Reddel RR
    PLoS One; 2012; 7(11):e50062. PubMed ID: 23185534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compromised Telomeric Heterochromatin Promotes ALTernative Lengthening of Telomeres.
    Voon HPJ; Collas P; Wong LH
    Trends Cancer; 2016 Mar; 2(3):114-116. PubMed ID: 28741530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic and prognostic utility of incorporating DAXX, ATRX, and alternative lengthening of telomeres to the evaluation of pancreatic neuroendocrine tumors.
    Heaphy CM; Singhi AD
    Hum Pathol; 2022 Nov; 129():11-20. PubMed ID: 35872157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative Lengthening of Telomeres Phenotype Predicts Progression Risk in Noninsulinomas in a Chinese Cohort.
    Ban X; Mo S; Lu Z; Jia C; Shao H; Yan J; Chang X; Mao X; Wu Y; Zhang Y; Fan X; Yu S; Chen J
    Neuroendocrinology; 2022; 112(5):510-522. PubMed ID: 34348341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity.
    Lovejoy CA; Takai K; Huh MS; Picketts DJ; de Lange T
    PLoS Biol; 2020 Jan; 18(1):e3000594. PubMed ID: 31895940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma.
    Fan HC; Chen CM; Chi CS; Tsai JD; Chiang KL; Chang YK; Lin SZ; Harn HJ
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30625996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas.
    Abedalthagafi M; Phillips JJ; Kim GE; Mueller S; Haas-Kogen DA; Marshall RE; Croul SE; Santi MR; Cheng J; Zhou S; Sullivan LM; Martinez-Lage M; Judkins AR; Perry A
    Mod Pathol; 2013 Nov; 26(11):1425-32. PubMed ID: 23765250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reprint of: The Diagnostic and Prognostic Utility of Incorporating DAXX, ATRX, and Alternative Lengthening of Telomeres (ALT) to the Evaluation of Pancreatic Neuroendocrine Tumors (PanNETs).
    Heaphy CM; Singhi AD
    Hum Pathol; 2023 Feb; 132():1-11. PubMed ID: 36702689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution telomere fluorescence in situ hybridization reveals intriguing anomalies in germ cell tumors.
    Shekhani MT; Barber JR; Bezerra SM; Heaphy CM; Gonzalez Roibon ND; Taheri D; Reis LO; Guner G; Joshu CE; Netto GJ; Meeker AK
    Hum Pathol; 2016 Aug; 54():106-12. PubMed ID: 27085557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological analysis of ATRX, DAXX and NOTCH receptor expression in angiosarcomas.
    Panse G; Chrisinger JS; Leung CH; Ingram DR; Khan S; Wani K; Lin H; Lazar AJ; Wang WL
    Histopathology; 2018 Jan; 72(2):239-247. PubMed ID: 28796347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATRX represses alternative lengthening of telomeres.
    Napier CE; Huschtscha LI; Harvey A; Bower K; Noble JR; Hendrickson EA; Reddel RR
    Oncotarget; 2015 Jun; 6(18):16543-58. PubMed ID: 26001292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia.
    Rodriguez FJ; Brosnan-Cashman JA; Allen SJ; Vizcaino MA; Giannini C; Camelo-Piragua S; Webb M; Matsushita M; Wadhwani N; Tabbarah A; Hamideh D; Jiang L; Chen L; Arvanitis LD; Alnajar HH; Barber JR; Rodríguez-Velasco A; Orr B; Heaphy CM
    Brain Pathol; 2019 Jan; 29(1):126-140. PubMed ID: 30192422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis.
    Hackeng WM; Brosens LA; Poruk KE; Noë M; Hosoda W; Poling JS; Rizzo A; Campbell-Thompson M; Atkinson MA; Konukiewitz B; Klöppel G; Heaphy CM; Meeker AK; Wood LD
    Hum Pathol; 2016 Oct; 56():93-100. PubMed ID: 27342911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors.
    Chou A; Itchins M; de Reuver PR; Arena J; Clarkson A; Sheen A; Sioson L; Cheung V; Perren A; Nahm C; Mittal A; Samra JS; Pajic M; Gill AJ
    Hum Pathol; 2018 Dec; 82():249-257. PubMed ID: 30081149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a novel diagnostic gene expression signature to discriminate uterine leiomyoma from leiomyosarcoma.
    Adams CL; Dimitrova I; Post MD; Gibson L; Spillman MA; Behbakht K; Bradford AP
    Exp Mol Pathol; 2019 Oct; 110():104284. PubMed ID: 31301306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATRX-DAXX Complex Expression Levels and Telomere Length in Normal Young and Elder Autopsy Human Brains.
    Cavalcante SG; Silva CPN; Sola PR; Tanaka LY; Oba-Shinjo SM; Marie SKN
    DNA Cell Biol; 2019 Sep; 38(9):955-961. PubMed ID: 31361513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional Loss of
    Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
    Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benign metastasizing leiomyoma of the lung: clinicopathologic, immunohistochemical, and micro-RNA analyses.
    Nuovo GJ; Schmittgen TD
    Diagn Mol Pathol; 2008 Sep; 17(3):145-50. PubMed ID: 18382364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of DAXX and ATRX expression on telomere length and prognosis of breast cancer patients.
    Hussien MT; Shaban S; Temerik DF; Helal SR; Mosad E; Elgammal S; Mostafa A; Hassan E; Ibrahim A
    J Egypt Natl Canc Inst; 2020 Aug; 32(1):34. PubMed ID: 32856116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis.
    Patton KT; Cheng L; Papavero V; Blum MG; Yeldandi AV; Adley BP; Luan C; Diaz LK; Hui P; Yang XJ
    Mod Pathol; 2006 Jan; 19(1):130-40. PubMed ID: 16357844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.